PMC:7534795 / 106288-106624 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T38","span":{"begin":15,"end":20},"obj":"Body_part"},{"id":"T39","span":{"begin":93,"end":98},"obj":"Body_part"},{"id":"T40","span":{"begin":106,"end":111},"obj":"Body_part"},{"id":"T41","span":{"begin":163,"end":172},"obj":"Body_part"}],"attributes":[{"id":"A38","pred":"fma_id","subj":"T38","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A39","pred":"fma_id","subj":"T39","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A40","pred":"fma_id","subj":"T40","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"uding elevated blood pressure, excessive recruitment and infiltration of inflammatory immune cells to the heart as well as increased secretion of pro-inflammatory cytokines. Reduced ACE2 levels are associated with decreased formation of Ang-(1–7) and thus loss of its vasodilatory, anti-inflammatory and CVD-protective effects. Therefor"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T140","span":{"begin":15,"end":20},"obj":"Body_part"},{"id":"T141","span":{"begin":106,"end":111},"obj":"Body_part"}],"attributes":[{"id":"A140","pred":"uberon_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A141","pred":"uberon_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"uding elevated blood pressure, excessive recruitment and infiltration of inflammatory immune cells to the heart as well as increased secretion of pro-inflammatory cytokines. Reduced ACE2 levels are associated with decreased formation of Ang-(1–7) and thus loss of its vasodilatory, anti-inflammatory and CVD-protective effects. Therefor"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T74","span":{"begin":15,"end":20},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T75","span":{"begin":15,"end":20},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T76","span":{"begin":93,"end":98},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T77","span":{"begin":106,"end":111},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T78","span":{"begin":106,"end":111},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T79","span":{"begin":106,"end":111},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T80","span":{"begin":106,"end":111},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"}],"text":"uding elevated blood pressure, excessive recruitment and infiltration of inflammatory immune cells to the heart as well as increased secretion of pro-inflammatory cytokines. Reduced ACE2 levels are associated with decreased formation of Ang-(1–7) and thus loss of its vasodilatory, anti-inflammatory and CVD-protective effects. Therefor"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T16","span":{"begin":133,"end":142},"obj":"http://purl.obolibrary.org/obo/GO_0046903"},{"id":"T17","span":{"begin":224,"end":233},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":"uding elevated blood pressure, excessive recruitment and infiltration of inflammatory immune cells to the heart as well as increased secretion of pro-inflammatory cytokines. Reduced ACE2 levels are associated with decreased formation of Ang-(1–7) and thus loss of its vasodilatory, anti-inflammatory and CVD-protective effects. Therefor"}

{"project":"LitCovid-sentences","denotations":[{"id":"T661","span":{"begin":174,"end":327},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"uding elevated blood pressure, excessive recruitment and infiltration of inflammatory immune cells to the heart as well as increased secretion of pro-inflammatory cytokines. Reduced ACE2 levels are associated with decreased formation of Ang-(1–7) and thus loss of its vasodilatory, anti-inflammatory and CVD-protective effects. Therefor"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2994","span":{"begin":182,"end":186},"obj":"Gene"},{"id":"2995","span":{"begin":237,"end":245},"obj":"Gene"},{"id":"3001","span":{"begin":304,"end":307},"obj":"Disease"}],"attributes":[{"id":"A2994","pred":"tao:has_database_id","subj":"2994","obj":"Gene:59272"},{"id":"A2995","pred":"tao:has_database_id","subj":"2995","obj":"Gene:7108"},{"id":"A3001","pred":"tao:has_database_id","subj":"3001","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"uding elevated blood pressure, excessive recruitment and infiltration of inflammatory immune cells to the heart as well as increased secretion of pro-inflammatory cytokines. Reduced ACE2 levels are associated with decreased formation of Ang-(1–7) and thus loss of its vasodilatory, anti-inflammatory and CVD-protective effects. Therefor"}